How you price your drugs is a big and important decision. But if you’re like most pharmaceutical companies, you do not have a comprehensive system that gives your global teams visibility into pricing decisions through real-time data and analytics. Ready to boost your margins by optimizing your product pricing across regions and reference ecosystems from launch through retirement?

Watch this virtual session to get the insights and controls you need to more efficiently track and govern prices, optimize launch sequences, and simulate IRP events. You’ll also get a first-hand look at why Model N and GPI joined forces, addressing global pricing challenges – and delivering the industry’s only end-to-end, global revenue solution.

Model N’s industry-leading Global Price Management (GPM) suite of products that help pharmaceutical companies track and govern prices, optimize launch sequences, simulate IRP events, and derive insights, are now integrated with GPI Pulse, delivering best-in-class competitor pricing and IRP rules data instantly into Model N GPM without the hassle of manual updates and outdated data.

Key takeaways:

• Ways to address the challenges associated with reference pricing.
• Innovative considerations for global launch strategies.
• Tips for achieving pricing success.
• How Model N and GPI together can bring real-time insights and analysis to your organization.
• How pharma companies are utilizing expert-level business and advisory services to ensure they are making the most well-informed pricing decisions across the world.